BU-NOT-SET

CONTACT US
The outlook for a year of change
  • Industry trends
Eyes
Insight
Can oral solid dose keep its place as the leading dosage form?
  • Drug product
Eyes
Insight
Relocating API supply to avoid over-reliance
  • Drug substance
Eyes
Insight
Modified release fixed dose combination product with two poorly soluble drug substances
  • Drug product
pellets
Case study
Patient centricity during drug development and commercialisation
  • Drug product
Eyes
Insight
10 considerations to kick-start your drug development journey
  • Drug product
Eyes
Insight
Guidance for start-ups on drug development
  • Drug product
Eyes
Insight
Drug development for start-ups
  • Drug product
  • Drug substance
Test tubes
White paper
Optimising environmental sustainability
  • Sustainability
Eyes
Insight
Case study
  • Drug product
  • Manufacturing
Accelerating tablet tech-transfer through predictive modelling
Case study
  • Drug product
  • Manufacturing
Tackling assay variability in liquid vials: A data-driven approach to overcoming challenges
Fact sheet
  • Drug product
  • Manufacturing
Scalable solutions for high potent manufacturing
Insight
  • Drug product
  • Manufacturing
The stabilising power of lyophilisation in next-generation therapeutics
Insight
  • Drug product
  • Manufacturing
Unlocking the power of advanced sterile packaging
Fact sheet
  • Biologics
  • Manufacturing
Advancing continuous bioprocessing with Recimagine™
White paper
  • Biologics
  • Manufacturing
Advanced Bio is advancing rAAV production
White paper
  • Biologics
  • Manufacturing
Advanced Bio Is advancing LNP formulation
White paper
  • Drug product
  • Manufacturing
Optimising drug formulation: The critical role of granulation